Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joela Mathews

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Neuroimmunology|June 17, 2021
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statementSaúl Reyes, Anthony L Cunningham, Tomas Kalincik, et al.
Multiple Sclerosis and Related Disorders|November 13, 2018
Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policiesZhifeng Mao, César Álvarez-González, Kimberley Allen-Philbey, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2022
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patientsKimberley Allen-Philbey, Stefania De Trane, Zhifeng Mao, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Neuroimmunology|June 17, 2021
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statementSaúl Reyes, Anthony L Cunningham, Tomas Kalincik, et al.
Multiple Sclerosis and Related Disorders|November 13, 2018
Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policiesZhifeng Mao, César Álvarez-González, Kimberley Allen-Philbey, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2022
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patientsKimberley Allen-Philbey, Stefania De Trane, Zhifeng Mao, et al.
Pageof 2